Cyclovirobuxine D Exerts Anticancer Effects by Suppressing the EGFR-FAK-AKT/ERK1/2-Slug Signaling Pathway in Human Hepatocellular Carcinoma
2010 ◽
Vol 58
(2)
◽
pp. 814-820
◽
2013 ◽
Vol 43
(6)
◽
pp. 1951-1959
◽
2020 ◽
Vol 254
◽
pp. 112732
◽
2020 ◽
Vol 393
(5)
◽
pp. 897-908
◽
Keyword(s):
2018 ◽